Rybelsus 3mg
₱6,000 per month
Full Description
Rybelsus is an FDA-approved prescription medication for adults with type 2 diabetes mellitus. As the first oral GLP-1 receptor agonist, it mimics natural hormones to stimulate insulin release, regulate glucose levels, and slow digestion—helping to manage blood sugar effectively.
Clinical studies have shown that patients on the highest dose (14 mg) experienced improved blood sugar control and an average weight loss of 4.4 kg over 52 weeks.
Rybelsus is intended to be used alongside diet and exercise to improve glycemic control in patients with type 2 diabetes.
In this plan
• Prescription Consultation – A licensed healthcare professional will assess your suitability for Rybelsus.
• Convenient Home Delivery – Get your medication delivered discreetly to your door.
• Ongoing Support – Our medical team provides follow-up guidance for safe and effective use.
Features
• Clinically Proven – Shown to lower blood sugar levels and support weight loss in patients with type 2 diabetes.
• First Oral GLP-1 Medication – No need for injections; easy-to-take daily tablet.
• Supports Insulin Regulation – Stimulates the body’s natural insulin response to control blood sugar.
• Gradual Dose Adjustment – Available in 3 mg, 7 mg, and 14 mg to optimize effectiveness.
• May Support Weight Loss – Clinical trials showed patients lost an average of 4.4 kg over 52 weeks.
Directions
• Take 1 tablet daily in the morning with a sip of plain water (no more than 120 mL).
• Wait at least 30 minutes before eating, drinking, or taking other medications.
• Dosing Schedule:
- • Start with 3 mg once daily for the first 4 weeks.
- • Increase to 7 mg daily.
- • If needed, increase to 14 mg daily for maximum benefit.
• Follow your doctor’s advice on usage and continue a balanced diet and exercise plan for optimal results.
Learn More (Clinical studies)
• A 52-week clinical trial found that participants on 14 mg of oral semaglutide lost an average of 4.4 kg while improving blood sugar control.*
• Another study on 667 patients found that oral semaglutide (50 mg) resulted in 15.1% weight loss. **
*DOI: 10.1016/S0140-6736(19)31271-1
**Clinical Study by Novo Nordisk
How it works.
- Speak to a Doctor via online video consultation.
During your consultation, our Doctor will determine if you are eligible for medication. If you are, they will write a prescription and let you know more about what to expect and how to administer the medication.
- Receive medication.
Your medication will be shipped out the same day in a discreet packaging to your door.
- Ongoing care and support.
As part of your treatment plan, you’ll receive on-demand medical support via video or chat and a nutritional guide prepared by our Nutritionist to maximise your results with lifestyle changes.
Our medical team are with you at every step of the way.
OVA’s weight loss plans are co-designed with Dr. Ben Ng, Singapore’s leading endocrinologist and Chief Medical Officer at OVA. A senior consultant with over 20 years of clinical experience, Dr. Ng is renowned for his expertise in diagnosing and treating obesity, diabetes, thyroid disorders, and a broad spectrum of metabolic and endocrine conditions.